好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Efficacy and Tolerability of SPN-804, a Novel, Once-Daily Extended-Release Formulation of Oxcarbazepine as Adjunctive Therapy in Patients with Refractory Partial Seizures
Epilepsy
(-)
101
Authors/Disclosures
Paolo Baroldi (Supernus Pharmaceuticals, Inc.) No disclosure on file
Scott Brittain (Supernus Pharmaceuticals, Inc.) No disclosure on file
No disclosure on file
Janet Johnson No disclosure on file
Mahlon R. DeLong, MD (Emory University SOM) No disclosure on file
Bastiaan R. Bloem, MD, PhD (Radboud University Nijmegen Medical Centre) No disclosure on file
Bastiaan R. Bloem, MD, PhD (Radboud University Nijmegen Medical Centre) No disclosure on file